Cigna Group CI
- Market cap
- $69.9B
- P/E
- 11.3×
Follow CI
Cigna Group (CI) EV/EBITDA
As of 25 September 2026, Cigna Group (CI) trades at a EV/EBITDA of 7.7×. Over the past ten years it has ranged from 7.0× (March 2020) to 18.1× (January 2019); the current reading is higher than 1% of that period. That is below the Healthcare Plans industry median of 10.9× and below the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 8.1× | (2.81%) |
| FY2024 | 8.4× | (15.41%) |
| FY2023 | 9.9× | (9.83%) |
| FY2022 | 10.9× | 12.02% |
| FY2021 | 9.8× | 8.47% |
| FY2020 | 9.0× | (3.62%) |
| FY2019 | 9.4× | (46.89%) |
| FY2018 | 17.6× | 48.92% |
| FY2017 | 11.8× | 19.75% |
| FY2016 | 9.9× | (5.08%) |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 7.7× | 1.57% |
| Mar 2026 | 7.6× | (6.19%) |
| Dec 2025 | 8.1× | (9.05%) |
| Sep 2025 | 8.9× | (8.92%) |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group | 7.7× |
| OSCR Oscar Health, Inc. compare | 8.4× |
| CVS CVS Health Corporation compare | 8.7× |
| ELV Elevance Health, Inc. compare | 9.0× |
| HUM Humana Inc. compare | 10.9× |
| MOH Molina Healthcare, Inc compare | 13.0× |
| UNH UnitedHealth Group Incorporated compare | 14.5× |
| Healthcare Plans industry median | 10.9× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement